Ozempic, Wegovy and Mounjaro face new FDA warning over a rare eye condition
- The US FDA has warned of a potential risk of serious vision loss linked to popular drugs like Ozempic and Wegovy.
- • The warning covers GLP-1 drugs, including Mounjaro, used to treat diabetes and obesity.
- The drugs may increase the risk of a rare eye condition called NAION, which can cause sudden vision loss.
- The FDA has asked manufacturers to update drug labels with the potential risk and advise patients on warning signs.
Source: ndtvprofit.com
Get 100 stories a day on the app
Read, watch & listen · Free on iOS & Android



